Surgery Partners Q4 2022 Earnings Report
Key Takeaways
Surgery Partners, Inc. announced its Q4 and full year 2022 results, with revenue increasing by 15.9% to $707.1 million for the quarter and 14.1% to $2.5 billion for the year. The company set its 2023 guidance with revenue expected to be greater than $2.75 billion and Adjusted EBITDA greater than $425 million.
Revenue increased 15.9% to $707.1 million in Q4 2022.
Days adjusted same-facility revenues increased 10.7% in Q4 2022.
Net loss attributable to common stockholders was $23.4 million for Q4 2022.
Adjusted EBITDA increased 5.6% to $120.8 million in Q4 2022.
Surgery Partners
Surgery Partners
Surgery Partners Revenue by Segment
Forward Guidance
The Company projects 2023 revenues to be greater than $2.75 billion, and projects 2023 Adjusted EBITDA to be greater than $425 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income